Article
2.3 Million Patients Are About to Vanish From Your Books (Here's What Nobody's Telling ASCs)
Exactrx Team · June 30, 2026

The patients aren't going away. Their coverage is.
When CMS published its interim final rule on June 3, 2026, requiring adult Medicaid enrollees aged 19 through 64 to meet an 80-hour-per-month work or community engagement threshold as a condition of eligibility, the coverage loss projections were stark: 2.3 million people removed from Medicaid rolls in FY 2027, rising to over 3 million in subsequent years.
For CFOs and revenue cycle leaders running ambulatory surgery centers and outpatient practices, the instinct may be to treat this as a Medicaid problem — something that affects safety-net hospitals and federally qualified health centers more than procedural and surgical settings. That instinct is worth interrogating. Medicaid-covered patients represent a portion of elective and semi-elective procedure volume at ASCs in expansion states, and when their coverage disappears, they don't vanish from the patient population. They arrive as self-pay or charity care — categories that carry a fundamentally different financial profile.
Compliance with the new requirements begins January 1, 2027. The comment period closes July 31, 2026. The window to model the downstream impact on your payer mix is now, not after the first quarter of next year shows an unexpected self-pay spike.
What the enrollment drop actually means for procedural volume
Medicaid's role in ASC payer mix varies considerably by geography, specialty, and facility type. In states that expanded Medicaid under the ACA, working-age adults gained coverage for services that previously fell through the cracks — including outpatient orthopedic, GI, and pain management procedures. The 2.3 million projected disenrollees are disproportionately concentrated in this population: adults aged 19 to 64, many of whom are employed in part-time or irregular-hours roles that may not consistently meet the 80-hours-per-month threshold.
The arithmetic for ASC administrators is not complicated. If a meaningful share of your Medicaid-covered procedure volume comes from patients in this demographic, a portion of that volume either delays, disappears, or converts to self-pay. None of those outcomes are neutral. Delayed procedures create episodic demand surges that are harder to schedule around. Disappeared volume reduces contribution margin directly. Self-pay conversions increase bad debt exposure and shift collection timelines.
CMS projects total ASC payments to reach $9.2 billion in 2026. That figure reflects the current payer mix. The work requirement rule, combined with other reimbursement pressures hitting the same facilities simultaneously, puts pressure on both the numerator and the denominator of the margin equation.
The compounding pressure from Medicare reimbursement changes
ASC and outpatient revenue cycle leaders are managing the Medicaid enrollment risk in parallel with a reimbursement environment that is itself under stress. The 2026 Medicare Physician Fee Schedule introduces a permanent 2.5 percent reduction applied to work relative value units for approximately 7,700 procedural and diagnostic codes — an efficiency adjustment that hits hardest in the specialties most represented in ASC procedure mix: radiology, cardiology, surgery, and anesthesiology.
For the first time, CMS has also finalized two separate conversion factors: $33.4009 for non-qualifying APM participants and $33.5675 for qualifying APM participants. Clinicians on ASC boards whose income is tied to fee-for-service volume will feel both changes directly — reduced wRVU value per procedure and a smaller base rate for those not participating in alternative payment models.
CMS is simultaneously removing 285 procedures from the inpatient-only list — 269 of them musculoskeletal — with the full IPO list eliminated by January 1, 2029. That migration creates new ASC-eligible volume, but only if facilities can capture it with adequate payer coverage. Medicaid disenrollment reduces the covered population available to fill that new capacity.
Prior authorization adds friction at the worst moment
The same patients who lose Medicaid coverage and attempt to reschedule under alternative coverage — or who gain new coverage through employer plans after documenting work hours — will encounter a prior authorization environment that remains burdensome despite ongoing reform.
Medicare Advantage insurers made 52.8 million prior authorization determinations in 2024, denying 4.1 million — 7.7 percent of requests. Of those denials, only 11.5 percent were appealed, but when appeals were filed, 80.7 percent were overturned. That gap between the overturn rate and the appeal rate represents recoverable revenue that most practices are not capturing.
As of January 1, 2026, payers are required to respond to prior authorization requests within 72 hours for expedited requests and 7 calendar days for standard requests. Electronic prior authorization interfaces go live on January 1, 2027. CMS estimates these policies will save approximately $15 billion over 10 years, but the near-term burden on provider staff remains real: completing prior authorizations currently costs providers $20 to $50 per hour and takes an average of 13 hours per week.
State-level reform is accelerating alongside the federal track. ASCO has tracked over 130 prior authorization bills in 42 states in 2026, with five becoming law. Utah's new law shortens response timelines and ensures prior authorizations for chronic conditions remain valid for 12 months. Washington now requires peer-to-peer review for adverse determinations and prohibits insurers from using automated review as the sole basis for denials. For ASC administrators negotiating payer contracts, these state-level provisions are becoming leverage points — and contract language that predates them may need to be revisited.
What revenue cycle leaders should do before January 1, 2027
Segment your Medicaid volume by patient age and procedure type now. The work requirement targets adults aged 19 to 64. Run a report that isolates Medicaid-covered procedure volume in that cohort, broken out by CPT code family. That segmentation tells you which service lines carry the highest exposure to enrollment loss and where self-pay conversion risk is concentrated.
Model three payer mix scenarios for 2027. A baseline (current mix holds), a moderate case (partial enrollment loss with some patients transitioning to employer or marketplace coverage), and a stress case (disenrolled patients become self-pay or defer care). Each scenario should feed into your monthly volume forecast and bad debt reserve assumptions. CFOs who have already stress-tested these scenarios before the January 1, 2027 compliance date will have a head start on board-level conversations that will otherwise happen reactively.
Audit your prior authorization appeal rate against the 80.7 percent overturn benchmark. If your facility's appeal overturn rate is lower than the national figure for Medicare Advantage, you are either selecting the wrong denials to appeal or not appealing enough of them. Either way, recoverable revenue is sitting on the table.
Review payer contracts for PA language before the January 2027 electronic interface deadline. The CMS electronic prior authorization requirement taking effect January 1, 2027 changes the technical infrastructure for PA submission. Contracts written under older workflows may have turnaround and escalation terms that become more enforceable — or less favorable — once electronic interfaces are live. Get your payer contracts in front of legal counsel with that timeline in mind.
Track the comment period. The interim final rule's comment period closes July 31, 2026. Industry associations and state Medicaid agencies will submit comments that may signal implementation delays, state opt-outs, or exemption expansions. Revenue cycle leaders who are monitoring that commentary will have earlier visibility into whether the 2.3 million projection holds or shifts.
Bottom line
The Medicaid work requirement is not a policy abstraction. It is a payer mix event with a known start date and a projected enrollment impact that will flow directly into ASC and outpatient revenue cycle performance. The facilities that model it now — alongside the wRVU reimbursement cuts, the prior authorization reform timeline, and the new IPO procedure migrations — will be positioned to act rather than react when January 2027 arrives.
Related: Exactrx Analytics
See how Exactrx Analytics surfaces payer behavior, denial patterns, and revenue leakage across your book of business.
Explore Analytics →Keep reading
Denial management is now one of the costliest jobs in the revenue cycle. The groups pulling ahead score claims for denial risk before they ever reach the payer.
A veteran ASC operator shares hard-won lessons on RCM timing, credentialing pitfalls, and where AI actually helps in ambulatory surgery centers.
CMS's 2026 skin substitute reclassification cuts $19.6B in Medicare spending. Here's what wound care and surgical leaders must do now.